Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Reports Manufacturing Progress for Innovative Bladder Cancer Imaging System
Imagin Medical believes the i/Blue System can revolutionize the current standard of care for bladder cancer patients by improving cancer visualization for removal, and potentially lowering recurrence rates Imagin Medical is leveraging the significant expertise in optics, electronics, software, and mechanical design of FDA-registered contract manufacturer, Lighthouse Imaging, to implement the final stage of the i/Blue(TM) Imaging System Lighthouse’s manufacturing program remains on track for product commercialization in 2022 Surgical imaging company Imagin Medical (CSE: IME) (OTCQB: IMEXF) is continuing progress with the commercial-stage manufacturing of its patented i/Blue Imaging System, an innovative technology that the company believes will revolutionize…